Cocrystal Pharma, Inc.
COCP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001412486
In the last 90 days, Cocrystal Pharma, Inc. insiders filed 2 open-market purchases and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $1.17M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Cocrystal Pharma, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 27 | 21 | −6 |
| SharesConverted for a 1-for-12 split | 1.13M | 1.07M | −63.5K (−5.6%) |
| Value | $3.95M | $2.08M | −$1.87M (−47.3%) |
New holders (2)
Institutions that held Cocrystal Pharma, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| The PNC Financial Services Group, Inc. | 18 | $36 | 0.00% |
| GWM Advisors LLC | 18 | $35 | 0.00% |
Sold out (8)
Institutions that held Cocrystal Pharma, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Verition Fund Management LLC | 160,000 | $47.0K |
| Citadel Advisors LLC | 79,918 | $23.0K |
| Virtu Financial LLC | 48,017 | $14.0K |
| Bank of New York Mellon Corp | 44,523 | $13.0K |
| Commonwealth Equity Services, LLC | 25,000 | $7.00K |
| Two Sigma Securities, LLC | 20,018 | $6.00K |
| National Asset Management, Inc. | 12,727 | $4.00K |
| Millennium Management LLC | 10,555 | $3.00K |